The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Origin and Role of a Subset of Tumor-Associated Neutrophils with Antigen-Presenting Cell Features in Early-Stage Human Lung Cancer
Open accessAbstract
SUMMARY Based on studies in mouse tumor models, granulocytes appear to play a tumor-promoting role. However, there are limited data about the phenotype and function of tumor-associated neutrophils (TANs) in humans. Here, we identify a subset of TANs that exhibited characteristics of both neutrophils and antigen-presenting cells (APC) in early-stage human lung cancer. These APC-like “hybrid neutrophils”, which originate from CD11b+CD15hiCD10−CD16low immature progenitors, are able to cross-present antigens, as well as trigger and augment anti-tumor T cell responses. IFN-γ and GM-CSF are requisite factors in the tumor that working through the Ikaros transcription factor, synergistically exert their APC-promoting effects on the progenitors. Overall, these data demonstrate the existence of a specialized TAN subset with anti-tumor capabilities in human cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., & Albelda, S. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,371
Self-citationNeutrophils in the activation and regulation of innate and adaptive immunity
Mantovani, A., Cassatella, M. A., Costantini, C., & Jaillon, S. (2011) · Nature Reviews Immunology · doi:10.1038/nri3024 · Cited by 3,027
Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer
Eruslanov, E. B., Bhojnagarwala, P. S., Quatromoni, J. G., Stephen, T. L., Ranganathan, A., Deshpande, C., Akimova, T., Vachani, A., Litzky, L., Hancock, W. W., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci77053 · Cited by 644
Self-citationOn the dual roles and polarized phenotypes of neutrophils in tumor development and progression
Piccard, H., Muschel, R. J., & Opdenakker, G. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.06.004 · Cited by 373
The mouse fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster
Lynch, D. H., Watson, M. L., Alderson, M. R., Baum, P. R., Miller, R. E., Tough, T., Gibson, M., Davis-Smith, T., Smiths, C. A., Hunter, K., et al. (1994) · Immunity · doi:10.1016/1074-7613(94)90106-6 · Cited by 331
Abi Abdallah, D. S., Egan, C. E., Butcher, B. A., & Denkers, E. Y. (2011) · International Immunology · doi:10.1093/intimm/dxr007 · Cited by 264
Gosselin, E. J., Wardwell, K., Rigby, W. F., & Guyre, P. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1482 · Cited by 258
Surface Antigen Changes during Normal Neutrophilic Development: A Critical Review
Elghetany, M. T. (2002) · Blood Cells, Molecules, and Diseases · doi:10.1006/bcmd.2002.0513 · Cited by 224
Matsushima, H., Geng, S., Lu, R., Okamoto, T., Yao, Y., Mayuzumi, N., Kotol, P. F., Chojnacki, B. J., Miyazaki, T., Gallo, R. L., et al. (2013) · Blood · doi:10.1182/blood-2012-07-445189 · Cited by 207
Radsak, M., Iking‐Konert, C., Stegmaier, S., Andrassy, K., & Hänsch, G. M. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00140.x · Cited by 201
Neutrophil Granulocyte–committed Cells Can Be Driven to Acquire Dendritic Cell Characteristics
Oehler, L., Majdic, O., Pickl, W. F., Stöckl, J., Riedl, E., Drach, J., Rappersberger, K., Geissler, K., & Knapp, W. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.7.1019 · Cited by 189
Ilie, M., Hofman, V., Ortholan, C., Bonnetaud, C., Coëlle, C., Mouroux, J., & Hofman, P. (2012) · Cancer · doi:10.1002/cncr.26456 · Cited by 179
The paradox of tumor-associated neutrophils: Fueling tumor growth with cytotoxic substances
Houghton, A. M. (2010) · Cell Cycle · doi:10.4161/cc.9.9.11297 · Cited by 166
Papathanasiou, P., Perkins, A. C., Cobb, B. S., Ferrini, R., Sridharan, R., Hoyne, G. F., Nelms, K. A., Smale, S. T., & Goodnow, C. C. (2003) · Immunity · doi:10.1016/s1074-7613(03)00168-7 · Cited by 159
Yáñez, A., Ng, M. Y., Hassanzadeh‐Kiabi, N., & Goodridge, H. S. (2015) · Blood · doi:10.1182/blood-2014-09-600833 · Cited by 144
Potter, N., & Harding, C. V. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2538 · Cited by 138
Neutrophils as effector cells for antibody-based immunotherapy of cancer
van Egmond, M., & Bakema, J. E. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.12.002 · Cited by 136
Neutrophil Involvement in Cross-Priming CD8+ T Cell Responses to Bacterial Antigens
Tvinnereim, A., Hamilton, S. E., & Harty, J. T. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1994 · Cited by 136
Iking‐Konert, C., Ostendorf, B., Sander, O., Jost, M., Wagner, C., Joosten, L., Schneider, M., & Hänsch, G. M. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.034132 · Cited by 132
Carus, A., Ladekarl, M. B., Hager, H., Pilegaard, H. K., Nielsen, P. S., & Donskov, F. N. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.03.003 · Cited by 128
Moon, E. K., Ranganathan, R., Eruslanov, E. B., Kim, S., Newick, K., O’Brien, S., Lo, A., Liu, X., Zhao, Y., & Albelda, S. Μ. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1070 · Cited by 127
Self-citationLenalidomide induces degradation of IKZF1 and IKZF3
Krönke, J., Hurst, S. N., & Ebert, B. L. (2014) · OncoImmunology · doi:10.4161/21624011.2014.941742 · Cited by 103
Ikaros regulates neutrophil differentiation
Dumortier, A., Kirstetter, P., Kastner, P., & Chan, S. H. (2003) · Blood · doi:10.1182/blood-2002-05-1336 · Cited by 100
Dai, Z.-J., Gao, J., Ma, X., Yan, K., Liu, X.-X., Kang, H., Zongzheng, J., Guan, H., & Wang, X.-J. (2012) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-31-28 · Cited by 100
Geng, S., Matsushima, H., Okamoto, T., Yao, Y., Lu, R., Page, K., Blumenthal, R., Ward, N. L., Miyazaki, T., & Takashima, A. (2013) · Blood · doi:10.1182/blood-2012-07-445197 · Cited by 99
Plasticity beyond Cancer Cells and the “Immunosuppressive Switch”
Granot, Z., & Fridlender, Z. G. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1502 · Cited by 93
Nagata, Y., Ono, S., Matsuo, M., Gnjatic, S., Valmori, D., Ritter, G., Garrett, W. S., Old, L. J., & Mellman, I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112331099 · Cited by 85
Quatromoni, J. G., Singhal, S. K., Bhojnagarwala, P. S., Hancock, W. W., Albelda, S. Μ., & Eruslanov, E. B. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.5ta0814-373 · Cited by 69
Self-citationVandenberghe, P., Delable, J., de Boer, M., & Ceuppens, J. L. (1993) · International Immunology · doi:10.1093/intimm/5.3.317 · Cited by 69
Poly's plea: membership to the club of APCs
Ashtekar, A. R., & Saha, B. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00235-7 · Cited by 56
Reprogramming of human postmitotic neutrophils into macrophages by growth factors
Araki, H., Katayama, N., Yamashita, Y., Mano, H., Fujieda, A., Usui, E., Mitani, H., Ohishi, K., Nishii, K., Masuya, M., et al. (2004) · Blood · doi:10.1182/blood-2003-08-2742 · Cited by 54
Ikaros Imposes a Barrier to CD8+ T Cell Differentiation by Restricting Autocrine IL-2 Production
O’Brien, S., Thomas, R. M., Wertheim, G. B. W., Zhang, F., Shen, H., & Wells, A. D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301992 · Cited by 53
Self-citationWagner, C., Iking‐Konert, C., Hug, F., Stegmaier, S., Heppert, V. G., Wentzensen, A., & Hänsch, G. M. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02963.x · Cited by 53
Köffel, R., Meshcheryakova, A., Warszawska, J. M., Hennig, A., Wagner, K., Jörgl, A., Gubi, D., Moser, D., Hladik, A., Hoffmann, U., et al. (2014) · Blood · doi:10.1182/blood-2014-07-588178 · Cited by 51
Neutrophil--mediated cytotoxicity against tumour cells: state of art.
Dallegri, F., & Ottonello, L. C. (1992) · PubMed · Cited by 14
Cited by
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
de Visser, K. E., & Joyce, J. A. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.016 · Cited by 4,059
Neutrophil diversity and plasticity in tumour progression and therapy
Jaillon, S., Ponzetta, A., Di Mitri, D., Santoni, A., Bonecchi, R., & Mantovani, A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0281-y · Cited by 1,285
The lung microenvironment: an important regulator of tumour growth and metastasis
Altorki, N. K., Markowitz, G. J., Gao, D., Port, J. L., Saxena, A., Stiles, B., McGraw, T., & Mittal, V. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-018-0081-9 · Cited by 1,150
Tumour-associated neutrophils in patients with cancer
Shaul, M. E., & Fridlender, Z. G. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0222-4 · Cited by 1,023
Neutrophil plasticity in the tumor microenvironment
Giese, M. A., Hind, L. E., & Huttenlocher, A. (2019) · Blood · doi:10.1182/blood-2018-11-844548 · Cited by 783
Metadata
- Authors
- Singhal, S., Bhojnagarwala, P. S., O'Brien, S., Moon, E. K., Garfall, A. L., Rao, A. S., Quatromoni, J. G., Stephen, T. L., Litzky, L., Deshpande, C., Feldman, M. D., Hancock, W. W., Conejo-Garcia, J. R., Albelda, S. M., & Eruslanov, E. B.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2016-07
- Volume
- 30
- Issue
- 1
- Pages
- 120-135
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2474950788
- Cited by
- 478
- References
- 37
- FWCI
- 15.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.